# Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem

> **NCT00781482** · PHASE4 · WITHDRAWN · sponsor: **Kettering Health Network**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** eszopiclone, zolpidem, placebo

## Key facts

- **NCT ID:** NCT00781482
- **Lead sponsor:** Kettering Health Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor elected not to conduct study at this time.
- **Last updated:** 2016-02-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781482, "Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00781482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*